NA
BDSI

Navellier & Associates’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Navellier & Associates’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,168
Closed -$175K – 271
2020
Q2 		$175K Sell
40,168
-48,630
-55% -$219K 0.04% 222
2020
Q1 		$337K Sell
88,798
-3,536
-4% -$17.4K 0.08% 167
2019
Q4 		$584K Buy
+92,334
New +$543K 0.09% 173

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Navellier & Associates's BDSI Position: Q3 2020 in Review

Navellier & Associates sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 40,168 shares — an estimated $175K sold.

Navellier & Associates first reported a position in BDSI in Q4 2019 and held it in 3 quarters. The position peaked at $584K in Q4 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • Navellier & Associates reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • Navellier & Associates sold 40,168 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $175K.
  • Navellier & Associates first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 3 quarters.
  • Navellier & Associates's BioDelivery Sciences International, Inc. position peaked at $584K in Q4 2019.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Navellier & Associates's 13F filing for Q3 2020, filed 9 Nov 2020.